Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
glp-1 treatments Weight Loss Medications Explained: Who Should Consider Them and Why Purchase Type:MB-1 | 6 Month Delivery rc-member-legacy-20-off|price:member-discount|otp:20.0:percent Frontiers | Association between
Frontiers | Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis
Work closely with your healthcare provider to explore all available diabetes and weight loss medications and their respective discount programs, to find a safe, effective, and affordable path for your weight loss journey.
rc-member-legacy-20-off|price:member-discount|otp:20.0:percent
Purchase Type:MB-1 | 6 Month Delivery
Your GP can: Assess your current weight, BMI, and metabolic health to determine clinical need Review existing treatment options that are currently licensed and available in the UK, which may include orlistat, naltrexone/bupropion (Mysimba), semaglutide 2.4 mg (Wegovy — approved by the MHRA for weight management and subject to NICE guidance on eligibility, service setting, and treatment duration), and tirzepatide (Mounjaro — check current MHRA and NICE status at the time of reading, as licensing and commissioning arrangements may have been updated) Discuss eligibility for NHS Tier 3 or Tier 4 specialist weight management services , in line with NICE guidance on obesity management, where pharmacotherapy is used as an adjunct to structured lifestyle intervention Signpost you to relevant clinical trials via the Be Part of Research portal or ClinicalTrials.gov if you wish to explore participation in retatrutide research It is important to approach information about investigational medicines with appropriate caution
